KalVista (KLST) CFO Brian Piekos sells $39,881 in stock

AI Summary

Brian Piekos, CFO of KalVista Pharmaceuticals (KLST), sold a total of $39,881 in company stock. This sale reflects ongoing management activity within the firm. Such transactions can influence investor perception regarding confidence in the company's future performance. Understanding insider selling patterns can be critical for investors assessing the stability and outlook of KLST.